Retina/Vitreous

Top Story

Oxurion enrolls first patient in clinical trial evaluating DME therapy

September 21, 2018

Adverum Biotechnologies receives fast track designation for wet AMD therapy

September 20, 2018
The FDA granted fast track designation for ADVM-022, a novel gene therapy candidate for the treatment of wet age-related macular degeneration, according to a press…

First patient enrolled in Oxurion trial evaluating anti-PIGF treatment

September 20, 2018
The first patient has been enrolled in a phase 2 open-label multicenter study to evaluate intravitreal THR-317, an anti-PIGF antibody, for the treatment of macular…

Allergan, International Diabetes Federation partner to fight DME

September 19, 2018
Allergan and the International Diabetes Federation have entered into a collaborative partnership to develop a global approach to screen, diagnose and manage diabetic…
More Headlines »
Clinical Science Imaging

Noninvasive Imaging of Mitochondrial Dysfunction in Dry Age-Related Macular Degeneration

Ophthalmic Surgery, Lasers and Imaging Retina, September 2012, Volume 43 Issue 5
Oxidative stress and mitochondrial dysfunction are implicated in the pathogenesis of age-related macular degeneration…
More »
CME

Uveitis 101 for Busy Retina Specialists

Case Discussions: Medical and Surgical Approaches in Managing Patients With Uveitis

This activity presents an update on differential diagnosis of noninfectious uveitis of the posterior segment (NIU-PS)…
More »
Resource Centers
Video
Meeting News

VIDEO: Early treatment with Iluvien reduces adjunctive treatment burden in DME

August 4, 2018
More »

Oxurion enrolls first patient in clinical trial evaluating DME therapy

September 21, 2018
The first patient has been enrolled in a phase 1 clinical trial to evaluate the safety of a single intravitreal injection of THR-687 in the treatment…

Adverum Biotechnologies receives fast track designation for wet AMD therapy

September 20, 2018
The FDA granted fast track designation for ADVM-022, a novel gene therapy candidate for the treatment of wet age-related macular degeneration…

First patient enrolled in Oxurion trial evaluating anti-PIGF treatment

September 20, 2018
The first patient has been enrolled in a phase 2 open-label multicenter study to evaluate intravitreal THR-317, an anti-PIGF antibody, for the…

Allergan, International Diabetes Federation partner to fight DME

September 19, 2018
Allergan and the International Diabetes Federation have entered into a collaborative partnership to develop a global approach to screen, diagnose and…

Nightstar gene therapy used in first US patient with X-linked retinitis pigmentosa

September 19, 2018
A patient at Bascom Palmer Eye Institute has become the first in the United States to receive an innovative gene therapy treatment for X-linked…

Second Sight receives $1.6 million grant for development of Orion cortical visual prosthesis

September 19, 2018
The National Institutes of Health has granted Second Sight Medical Products a $1.6 million grant in order to fund the early feasibility clinical…

BioTime names new CEO

September 18, 2018
Brian Culley has been appointed as CEO of BioTime, succeeding co-CEOs Adi Mohanty and Michael West, PhD, the company announced in a press release…

Blog

BLOG: Telemonitoring allows for earlier detection and timely treatment of AMD

September 18, 2018
Recently, I have predicted that telemedicine is poised to become more routinely used in our management of age-related macular degeneration patients…

August’s top retina headlines

September 17, 2018
FDA actions and coverage from the American Society of Retina Specialists meeting were some of the most-read retina-related articles on Healio.com/OSN…

OSN’s top news of the week

September 16, 2018
Here are some of the top stories of the past week on Healio.com/OSN:

Read OSN’s Sept. 10 publication exclusives online

September 15, 2018
The cover story in the Sept. 10, 2018, issue of Ocular Surgery News focused on retinal toxicity stemming from hydroxychloroquine dosing. Here are a…

FDA to review Eylea for diabetic retinopathy

September 13, 2018
The FDA has agreed to review a supplemental biologics license application of Eylea for the treatment of diabetic retinopathy, Regeneron announced in…

In the Journals

Visual recovery possible after eye injuries from hand-held laser pointers

September 12, 2018
Commercial hand-held laser pointers can inflict macular injuries, but good visual recovery is possible. A study included eight eyes of seven patients…

Apellis begins phase 3 clinical program for geographic atrophy treatment

September 12, 2018
A two-trial phase 3 clinical program for APL-2 for geographic atrophy has begun with the first patient enrolled in the DERBY trial and the first…

In the Journals

Retinal alterations noted in preclinical Alzheimer’s disease

September 10, 2018
Subjects with preclinical Alzheimer’s disease had a larger foveal avascular zone and decreased inner foveal thickness compared with subjects…

OSN’s top news of the week

September 9, 2018
Here are some of the top stories of the past week on Healio.com/OSN:

Practical pearls in pediatric vitreoretinal surgery

September 7, 2018
Pediatric retina surgery is not for the faint of heart. The stakes could not be higher for the youngest of our patients, and the margin between…

Point/Counter

Should a patient with signs of retinal toxicity be taken off HCQ completely, or are a reduced dose and additional screening more appropriate?

Ocular Surgery News U.S. Edition, September 10, 2018
Point Hydroxychloroquine is a drug used by many rheumatologists and dermatologists as a first-line agent to treat conditions from arthritis to lupus…

Lindstrom's Perspective

Ophthalmologists play important role for patients treated with hydroxychloroquine

Ocular Surgery News U.S. Edition, September 10, 2018
Richard L. Lindstrom, MD
Hydroxychloroquine has been used in American medicine since 1955. It is primarily prescribed to treat chloroquine-sensitive malaria, rheumatoid…

Surgical Maneuvers

Femtosecond laser assists implantation of miniature telescope

Ocular Surgery News U.S. Edition, September 10, 2018
Randal T. Pham, MD, MS, FACS
Age-related macular degeneration affects central vision and can result in significant visual acuity deterioration, thus negatively affecting a…

More Headlines »